Depression, Anxiety, Stress, and Health-Related Quality of Life Among Patients With Medication Overuse Headache in a Tertiary Headache Center: A Cross-Sectional Study
- PMID: 33626886
- DOI: 10.1176/appi.neuropsych.20070189
Depression, Anxiety, Stress, and Health-Related Quality of Life Among Patients With Medication Overuse Headache in a Tertiary Headache Center: A Cross-Sectional Study
Abstract
Objective: The investigators examined the association of patient-related and headache-related parameters and the effect of medication overuse headache (MOH); the occurrence of depression, anxiety, and stress; and the importance of different domains of health-related quality of life in these associations.
Methods: Eighty-three patients (women, N=72, men, N=11; mean age, 40.54 years, SD=11.58), who were first diagnosed with MOH during the study period were included in the analyses. The Headache Impact Test-6 (HIT-6), the 36-item Short-Form Survey (SF-36) Questionnaire for quality of life, and the Depression Anxiety Stress Scales were used.
Results: The findings revealed mild depression, moderate anxiety, and stress, as well as changes in all examined health domains, in the study patients (p<0.05). Risk factors were identified for higher HIT-6 scores (role functioning/physical functioning [odds ratio=0.977, p=0.024] and social functioning [odds ratio=0.963, p=0.032]); for depression (emotional well-being [odds ratio=0.928, p=0.007], social functioning [odds ratio=0.950, p=0.009], and the presence of comorbidity [odds ratio=5.417, p=0.013]); for anxiety (age [odds ratio=1.091, p=0.007], MOH duration [odds ratio=1.422, p=0.047], emotional well-being [odds ratio=0.933, p=0.012], and social functioning [odds ratio=0.943, p=0.001]); and for stress (emotional well-being [odds ratio=0.902, p<0.001]).
Conclusions: MOH has a significant negative impact on the personal, family, and social life of patients and is associated with depression, anxiety, and stress. Patients' age, duration of MOH, presence of comorbidities, and adverse effects of physical, emotional, and social dysfunction are particularly important contributors to the negative effects of MOH.
Keywords: Anxiety; Depression; Medication Overuse Headache; Quality of Life; Stress.
Similar articles
-
Medication overuse, healthy lifestyle behaviour and stress in chronic headache: Results from a population-based representative survey.Cephalalgia. 2016 Jan;36(1):15-28. doi: 10.1177/0333102415578430. Epub 2015 Mar 24. Cephalalgia. 2016. PMID: 25804645
-
Evaluation of Risk Factors in Patients With Chronic Daily Headache and Medication-Overuse Headache.Brain Behav. 2025 Mar;15(3):e70407. doi: 10.1002/brb3.70407. Brain Behav. 2025. PMID: 40079498 Free PMC article.
-
Quality of life, depression, and anxiety 6 months after inpatient withdrawal in patients with medication overuse headache: an observational study.Clin J Pain. 2012 May;28(4):284-90. doi: 10.1097/AJP.0b013e3182321d35. Clin J Pain. 2012. PMID: 22001669
-
Medication overuse headache.Headache. 2014 Jul-Aug;54(7):1251-7. doi: 10.1111/head.12408. Epub 2014 Jul 2. Headache. 2014. PMID: 24990298 Review.
-
[Alexithymic features and emotional distress in patients with chronic tension-type headache (CTTH) and medication-overuse headache (MOH)].Clin Ter. 2008 Nov-Dec;159(6):397-403. Clin Ter. 2008. PMID: 19169598 Review. Italian.
Cited by
-
Association of Acute Headache of COVID-19 and Anxiety/Depression Symptoms in Adults Undergoing Post-COVID-19 Rehabilitation.J Clin Med. 2022 Aug 26;11(17):5002. doi: 10.3390/jcm11175002. J Clin Med. 2022. PMID: 36078932 Free PMC article.
-
A Descriptive Review of Medication-Overuse Headache: From Pathophysiology to the Comorbidities.Brain Sci. 2023 Oct 1;13(10):1408. doi: 10.3390/brainsci13101408. Brain Sci. 2023. PMID: 37891777 Free PMC article. Review.
-
The Ruminative Thought Style with Associated Anxiety Influences the Occurrence of Medication-Overuse Headache.J Clin Neurol. 2021 Jul;17(3):419-427. doi: 10.3988/jcn.2021.17.3.419. J Clin Neurol. 2021. PMID: 34184450 Free PMC article.
-
Management of medication overuse (MO) and medication overuse headache (MOH) S1 guideline.Neurol Res Pract. 2022 Aug 29;4(1):37. doi: 10.1186/s42466-022-00200-0. Neurol Res Pract. 2022. PMID: 36031642 Free PMC article.
-
Depression and Anxiety Symptoms in Headache Disorders: An Observational, Cross-Sectional Study.Neurol Int. 2024 Mar 18;16(2):356-369. doi: 10.3390/neurolint16020026. Neurol Int. 2024. PMID: 38525706 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical